Shares Outstanding for DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's latest reported diluted shares outstanding is 398.90M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
DXCM
Currently viewingShares OutstandingSwitch metric
Latest period
398.90M
YoY change
-1.7%
5Y CAGR
+0.8%
Peak year (2021)
428.80M
Latest annual
405.50M
Shares Outstanding history chart for DexCom (DXCM) from 2000 to 2025
Shares Outstanding history table for DexCom (DXCM) from 2000 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 405.50M | -1.7% | ||
| 2024 | 412.70M | -3.0% | ||
| 2023 | 425.50M | -0.5% | ||
| 2022 | 427.50M | -0.3% | ||
| 2021 | 428.80M | +9.9% | ||
| 2020 | 390.00M | +5.6% | ||
| 2019 | 369.20M | +4.6% | ||
| 2018 | 352.80M | +2.2% | ||
| 2017 | 345.20M | +3.2% | ||
| 2016 | 334.40M | +4.8% | ||
| 2015 | 319.20M | +6.1% | ||
| 2014 | 300.80M | +5.8% | ||
| 2013 | 284.40M | +3.5% | ||
| 2012 | 274.80M | +4.7% | ||
| 2011 | 262.40M | +15.3% | ||
| 2010 | 227.60M | +28.3% | ||
| 2009 | 177.39M | +50.4% | ||
| 2008 | 117.95M | +4.1% | ||
| 2007 | 113.25M | +4.0% | ||
| 2006 | 108.94M | +43.8% | ||
| 2005 | 75.78M | +728.7% | ||
| 2004 | 9.14M | +5.3% | ||
| 2003 | 8.68M | +6.0% | ||
| 2002 | 8.18M | +7.9% | ||
| 2001 | 7.59M | +9.8% | ||
| 2000 | 6.91M | — |
Shares Outstanding values are taken from DexCom's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of DexCom (DXCM) diluted shares outstanding is 405.50M – edged down 1.7% year-over-year.
Across 2020–2025 (5 years), DexCom diluted shares outstanding produced a CAGR of +0.8% – with the latest reading among the more recent periods of the dataset.
DexCom diluted shares outstanding declined from 428.80M in 2021 to 405.50M in 2025, a 5.4% drawdown.
2021 marks the peak diluted shares outstanding at 428.80M, with the historical low of 6.91M recorded in 2000.
Among 8 Healthcare peers, DexCom (DXCM) ranks 9th; the peer median for diluted shares outstanding is 1.34B.
DexCom Shares Outstanding by Year
DexCom Shares Outstanding 2025: 405.50M
DexCom diluted shares outstanding in 2025 was 405.50M, edged down 1.7% below 2024.
DexCom Shares Outstanding 2024: 412.70M
DexCom diluted shares outstanding in 2024 was 412.70M, edged down 3.0% below 2023.
DexCom Shares Outstanding 2023: 425.50M
DexCom diluted shares outstanding in 2023 was 425.50M, edged down 0.5% below 2022.
DexCom Shares Outstanding 2022: 427.50M
DexCom diluted shares outstanding in 2022 was 427.50M, edged down 0.3% below 2021.
DexCom Shares Outstanding 2021: 428.80M
DexCom diluted shares outstanding in 2021 was 428.80M.
See more financial history for DexCom (DXCM).
Sector peers — Shares Outstanding
Companies in the same sector as DexCom, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
Frequently asked questions
What is DexCom's diluted shares outstanding?
- Latest reported diluted shares outstanding for DexCom (DXCM) is 398.90M (period ending December 31, 2025).
How has DexCom diluted shares outstanding changed year-over-year?
- DexCom (DXCM) diluted shares outstanding changed -1.7% year-over-year on the latest annual filing.
What is the long-term growth rate of DexCom diluted shares outstanding?
- DexCom (DXCM) diluted shares outstanding compound annual growth rate is +0.8% over the most recent 5 years available.
When did DexCom diluted shares outstanding hit its highest annual value?
- DexCom diluted shares outstanding reached its highest annual value of 428.80M in 2021.
What was DexCom diluted shares outstanding in 2024?
- DexCom (DXCM) diluted shares outstanding in 2024 was 412.70M.
What was DexCom diluted shares outstanding in 2025?
- DexCom (DXCM) diluted shares outstanding in 2025 was 405.50M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DXCM Overview
Company profile, financial tools, and key metrics
DXCM Revenue Counter
Earns $147.83 every second. See per minute, hour, and day.
DXCM Earnings Counter
Earns $26.52 per second net profit. See per minute, hour, and day.
DXCM Economic Scale
Exceeds Suriname's GDP. Compare with world economies.
DXCM What If Invested
What if you had invested $1,000? See historical returns from any date.
DXCM How It Makes Money
Discover visual breakdown of $4.66B in revenue — where it comes from and where it goes.
DXCM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DXCM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DXCM Daily Price Character
Explosive · 49.4% historical win rate (green days). Streaks & record days.
DXCM Buybacks
1.95% TTM buyback yield. Shareholder yield & SBC comparison.
DXCM Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.